Ladan Zand, Fernando C Fervenza, Rosanna Coppo. Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients.Clinical kidney journal. 2023, 16 (Suppl 2): ii19-ii27
Fernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M Sevillano, Manuel Praga. Targeting complement in IgA nephropathy.Clinical kidney journal. 2023, 16 (Suppl 2): ii28-ii39
Francesco Locatelli, Lucia Del Vecchio, Claudio Ponticelli. Systemic and targeted steroids for the treatment of IgA nephropathy.Clinical kidney journal. 2023, 16 (Suppl 2): ii40-ii46
Dita Maixnerova, Jan Hartinger, Vladimir Tesar. Expanding options of supportive care in IgA nephropathy.Clinical kidney journal. 2023, 16 (Suppl 2): ii47-ii54
Francesco Paolo Schena, Carlo Manno, Giovanni Strippoli. Understanding patient needs and predicting outcomes in IgA nephropathy using data analytics and artificial intelligence: a narrative review.Clinical kidney journal. 2023, 16 (Suppl 2): ii55-ii61
See Cheng Yeo, Jonathan Barratt. The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy.Clinical kidney journal. 2023, 16 (Suppl 2): ii9-ii18
Carmine Zoccali, Vianda Stel, Friedo Dekker, Kitty J Jager. A new methodological series in : from basic-level methodology to artificial intelligence in medicine.Clinical kidney journal. 2023, 16 (12): 2303
Leonor Fayos De Arizón, Elizabeth R Viera, Melissa Pilco, Alexandre Perera, Gabriel De Maeztu, Anna Nicolau, Monica Furlano, Roser Torra. Artificial intelligence: a new field of knowledge for nephrologists?Clinical kidney journal. 2023, 16 (12): 2314-2326
Magdalena Jankowska, María José Soler, Kate I Stevens, Roser Torra. Why do we keep ignoring sex in kidney disease?Clinical kidney journal. 2023, 16 (12): 2327-2335
Shubhi Pandey, Amar Kalaria, Kenar D Jhaveri, Sandra M Herrmann, Agnes S Kim. Management of hypertension in patients with cancer: challenges and considerations.Clinical kidney journal. 2023, 16 (12): 2336-2348
Simona Granata, Giovanni Stallone, Gianluigi Zaza. mRNA as a medicine in nephrology: the future is now.Clinical kidney journal. 2023, 16 (12): 2349-2356
Alexandre Persu, Maria S Stoenoiu, Frédéric Maes, Reinhold Kreutz, Giuseppe Mancia, Sverre E Kjeldsen. Late outcomes of renal denervation are more favourable than early ones: facts or fancies?Clinical kidney journal. 2023, 16 (12): 2357-2364
Gaye Hafez, Jolanta Malyszko, Aleksandra Golenia, Aleksandra Klimkowicz-Mrowiec, Ana Carina Ferreira, Mustafa Arıcı, Annette Bruchfeld, Dorothea Nitsch, Ziad A Massy, Marion Pépin, Giovambattista Capasso, Laila-Yasmin Mani, Sophie Liabeuf, . Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.Clinical kidney journal. 2023, 16 (12): 2378-2392